<?xml version="1.0" encoding="us-ascii"?>
<!-- EDGAR Online I-Metrix Xcelerate Risk Return XBRL Instance Document, based on XBRL 2.1  http://www.edgar-online.com/ -->
<!-- Created (UTC): 12/14/2012 5:07:31 PM -->
<!-- XBRL File Set ID: 0bd7ebc1-477c-4b57-b3f0-53589115d9f8 -->
<!-- App Version: 3.0.0.183, 5.1.2600.196608, 14.0 -->
<!-- Copyright (c) 2005-2012 EDGAR Online, Inc. All Rights Reserved. -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/2008/inlineXBRL/transformation" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:rr="http://xbrl.sec.gov/rr/2010-02-28" xmlns:dei="http://xbrl.us/dei/2009-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ck0000729528="http://WWW.AMERICANFUNDS.COM/20121206">
  <link:schemaRef xlink:href="ck0000729528-20121206.xsd" xlink:type="simple" />
  <context id="DocumentContext" xmlns="http://www.xbrl.org/2003/instance">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000729528</identifier>
    </entity>
    <period>
      <startDate>2012-12-06</startDate>
      <endDate>2012-12-06</endDate>
    </period>
  </context>
  <context id="CTXT_P0001S000008783member_S000008783member" xmlns="http://www.xbrl.org/2003/instance">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000729528</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:DocumentInformationDocumentAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">ck0000729528:P0001-S000008783Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">ck0000729528:S000008783Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-12-06</startDate>
      <endDate>2012-12-06</endDate>
    </period>
  </context>
  <dei:DocumentType contextRef="DocumentContext">Other</dei:DocumentType>
  <dei:DocumentPeriodEndDate contextRef="DocumentContext">2012-12-06</dei:DocumentPeriodEndDate>
  <dei:EntityRegistrantName contextRef="DocumentContext">AMERICAN FUNDS INSURANCE SERIES</dei:EntityRegistrantName>
  <dei:EntityCentralIndexKey contextRef="DocumentContext">0000729528</dei:EntityCentralIndexKey>
  <dei:AmendmentFlag contextRef="DocumentContext">false</dei:AmendmentFlag>
  <dei:DocumentCreationDate contextRef="DocumentContext">2012-12-05</dei:DocumentCreationDate>
  <dei:DocumentEffectiveDate contextRef="DocumentContext">2012-12-06</dei:DocumentEffectiveDate>
  <rr:ProspectusDate contextRef="DocumentContext">2012-05-01</rr:ProspectusDate>
  <rr:RiskReturnHeading contextRef="CTXT_P0001S000008783member_S000008783member">Global Discovery Fund SM &amp;nbsp;&amp;nbsp;&amp;nbsp; American Funds Insurance Series &#174;  &amp;nbsp;</rr:RiskReturnHeading>
  <ck0000729528:SupplementTextBlock contextRef="CTXT_P0001S000008783member_S000008783member">&lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;text-autospace:none"&gt;&lt;font style=&apos;font-size:24.0pt;font-family:"Arial","sans-serif"&apos;&gt;Global Discovery Fund &lt;/font&gt;&lt;font style=&apos;font-size:16.5pt;font-family:"Arial","sans-serif"&apos;&gt;SM&lt;/font&gt;&lt;font style=&apos;font-size:24.0pt;font-family:"Arial","sans-serif"&apos;&gt; &amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/font&gt;&lt;font style=&apos;font-size:18.0pt;font-family:"Arial","sans-serif"&apos;&gt;American Funds Insurance Series &lt;/font&gt;&lt;font style=&apos;font-size:12.5pt;font-family:"Times New Roman","serif"&apos;&gt;&#174;&lt;/font&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt;text-align: justify;line-height:normal;text-autospace:none"&gt;&lt;font style=&apos;font-size:10.0pt; font-family:"Times New Roman","serif"&apos;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;text-autospace:none"&gt;&lt;font style=&apos;font-size:18.0pt;font-family:"Arial","sans-serif"&apos;&gt;Summary Prospectus and Prospectus Supplement&lt;/font&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;text-autospace:none"&gt;&lt;font style=&apos;font-size:10.0pt;font-family:"Times New Roman","serif"&apos;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;text-autospace:none"&gt;&lt;font style=&apos;font-size:10.0pt;font-family:"Times New Roman","serif"&apos;&gt;&lt;br /&gt; &amp;nbsp;&lt;/font&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;text-autospace:none"&gt;&lt;font style=&apos;font-size:10.0pt;font-family:"Arial","sans-serif"&apos;&gt;December 5, 2012&lt;/font&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;text-autospace:none"&gt;&lt;font style=&apos;font-size:10.0pt;font-family:"Arial","sans-serif"&apos;&gt;(for Class 1 shares and Class 2 shares summary prospectuses of Global Discovery Fund dated May 1, 2012, and Class 1 shares and Class 2 shares prospectuses of American Funds Insurance Series dated May 1, 2012)&lt;/font&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;margin-bottom:10.0pt;line-height:115%;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;"&gt;&amp;nbsp;&lt;/p&gt;</ck0000729528:SupplementTextBlock>
  <rr:RiskHeading contextRef="CTXT_P0001S000008783member_S000008783member">The following paragraph is added to the &amp;quot;Principal Risks&amp;quot; section of Global Discovery Fund&#8217;s summary prospectuses and the &amp;quot;Principal Risks&amp;quot; section of the Global Discovery Fund summary portion of the American Funds Insurance Series&#8217; prospectuses:  &amp;nbsp;</rr:RiskHeading>
  <rr:RiskNarrativeTextBlock contextRef="CTXT_P0001S000008783member_S000008783member">&lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;text-autospace:none"&gt;&lt;font style=&apos;font-size:10.0pt;font-family:"Arial","sans-serif"&apos;&gt;On December 5, 2012, the Board of Trustees of the American Funds Insurance Series approved the merger of Global Discovery Fund into Global Growth Fund pursuant to Rule 17a-8 of the Investment Company Act of 1940. It is anticipated that the merger will be consummated in May of 2013; however, the fund reserves the right to delay the closing. At such time, beneficial owners of shares of Global Discovery Fund will automatically receive a proportionate number of shares of Global Growth Fund based on each fund&#8217;s net asset value at the time of the merger. Accordingly, when acquiring shares of Global Discovery Fund, you should also consider the strategies and risks of Global Growth Fund. Please see Global Growth Fund&#8217;s summary prospectus or the Global Growth Fund summary section of the American Funds Insurance Series prospectus for further information on the strategies and risks of Global Growth Fund.&lt;/font&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;margin-bottom:10.0pt;line-height:115%;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;"&gt;&amp;nbsp;&lt;/p&gt;</rr:RiskNarrativeTextBlock>
  <ck0000729528:SupplementClosingTextBlock contextRef="CTXT_P0001S000008783member_S000008783member">&lt;p class="MsoNormal" align="center" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt; text-align:center;line-height:normal;text-autospace:none"&gt;&lt;font style=&apos;font-size:10.0pt;font-family:"Arial","sans-serif"&apos;&gt;Keep this supplement with your summary prospectus or prospectus&lt;/font&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;text-autospace:none"&gt;&lt;font style=&apos;font-size:12.0pt;font-family:"Times New Roman","serif"&apos;&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-top:0in;margin-right:0in;margin-left:0in;margin-bottom:10.0pt;line-height:115%;font-size:11.0pt;font-family:&apos;calibri&apos;,&apos;sans-serif&apos;;"&gt;&amp;nbsp;&lt;/p&gt;</ck0000729528:SupplementClosingTextBlock>
  <link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
  </link:footnoteLink>
</xbrl>
